Association Between Depot-Medroxyprogesterone Acetate Injection and Periodontal Health in Reproductive Age Women: A Case Control Study in Iran

2016 ◽  
Vol 5 (3) ◽  
Author(s):  
Firozeh Bagheri ◽  
Mitra Tadayon ◽  
Poorandokht Afshari ◽  
Mahmoud Jahangirneghad ◽  
Mohammad Hosein Haghighizadeh
Keyword(s):  
Medroxyprogesterone Acetate ◽  
Case Control Study ◽  
Case Control ◽  
Reproductive Age ◽  
Periodontal Health ◽  
Depot Medroxyprogesterone Acetate ◽  
Reproductive Age Women ◽  
Control Study

scholarly journals The Relation of Diabetes Type 2 with Sexual Function among Reproductive Age Women in Iran, a Case-Control Study

2017 ◽  
Vol 2017 ◽  
pp. 1-5 ◽  
Author(s):  
Poorandokht Afshari ◽  
Shiva Yazdizadeh ◽  
Parvin Abedi ◽  
Homayra Rashidi
Keyword(s):  
Type 2 Diabetes ◽  
Sexual Function ◽  
Case Control Study ◽  
Case Control ◽  
Reproductive Age ◽  
Diabetic Patients ◽  
Healthy Women ◽  
Reproductive Age Women ◽  
Control Study

Background.Diabetic patients are at the greater risk of retinopathy, nephropathy, neuropathy, and sexual dysfunction compared to the general population.Objective.The aim of this study was to evaluate the sexual dysfunction in type 2 diabetes reproductive age women in Iran.Method.This was a case-control study carried out on 130 women with type 2 diabetes and 130 healthy women. The type 2 diabetes diagnosis was confirmed with abnormal fasting blood sugar, abnormal random blood sugar test, and abnormal level of HbA1C. Eligible women were requested to complete a demographic questionnaire and female sexual function index (FSFI). The chi-square test, independentt-test, and Multivariate Analysis of Covariance (MANCOVA) were used for analyzing data.Results.Results of this study showed that diabetic women had significantly lower sexual desire, arousal, lubrication, and orgasm and more pain compared to the healthy women (p<0.05). Also diabetic women had lower sexual satisfaction compared to the healthy women (p=0.002). The total score of sexual function was significantly lower in the diabetic women compared to the healthy women (21.25±7.04versus22.43±7.6,p=0.004).Conclusion.Results of this study showed that the score of all dimensions of sexual function in diabetic patients was lower than that in healthy women. Education and counseling about controlling diabetes and sexual function among diabetic women in reproductive age are recommended.

scholarly journals Determinants of short birth interval among ever married reproductive age women: A community based unmatched case control study at Dessie city administration, Northern Ethiopia

PLoS ONE ◽  
2020 ◽  
Vol 15 (12) ◽  
pp. e0243046
Author(s):  
Habtamu Shimels Hailemeskel ◽  
Tesfaye Assebe ◽  
Tadesse Alemayehu ◽  
Demeke Mesfin Belay ◽  
Fentaw Teshome ◽  
...  
Keyword(s):  
Birth Interval ◽  
Contraceptive Use ◽  
Case Control Study ◽  
Case Control ◽  
Reproductive Age ◽  
Age At First Birth ◽  
Community Based ◽  
Reproductive Age Women ◽  
Short Birth Interval ◽  
Control Study

Background Short birth interval is a universal public health problem resulting in adverse fetal, neonatal, child and maternal outcomes. In Ethiopia, more than 50% of the overall inter birth spacing is short. However, prior scientific evidence on its determinants is limited and even then findings are inconsistent. Methods A community -based unmatched case-control study was employed on 218 cases and 436 controls. Cases were ever married reproductive age women whose last delivery has been in the past five years with birth interval of less than 3 years between the latest two successive live births whereas those women with birth interval of 3–5 years were taken as controls. A multistage sampling technique was employed on 30% of the kebeles in Dessie city administration. A pre-tested interviewer based questionnaire was used to collect data by 16 trained diploma nurses and 8 health extension workers supervised by 4 BSc nurses. The collected data were cleaned, coded and double entered into Epi-data version 4.2 and exported to SPSS version 22. Binary logistic regression model was considered and those variables with P<0.25 in the bivariable analysis were entered in to final model after which statistical significance was declared at P< 0.05 using adjusted odds ratio at 95% CI. Result In this study, contraceptive use (AOR = 11.2, 95% CI: 5.95–21.15), optimal breast feeding for at least 2 years (AOR = 0.098, 95% CI:0.047–0.208), age at first birth <25 years (AOR = 0.36, 95% CI: 0.282–0.761), having male preceding child (AOR = 0.46, 95% CI: 0.166–0.793) and knowing the duration of optimum birth interval correctly (AOR = 0.45, 95% CI: 0.245–0.811) were significant determinants of short birth interval. Conclusion Contraceptive use, duration of breast feeding, age at first birth, preceding child sex and correct understanding of the duration of birth interval were significant determinants of short birth interval. Fortunately, all these significant factors are likely modifiable. Thus, the existing efforts of optimizing birth interval should be enhanced through proper designation and implementation of different strategies on safe breastfeeding practice, modern contraceptive use and maternal awareness about the health merits of optimum birth interval.

Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study

2012 ◽  
Vol 119 (6) ◽  
pp. 672-677 ◽  
Author(s):  
S Wilailak ◽  
C Vipupinyo ◽  
V Suraseranivong ◽  
K Chotivanich ◽  
C Kietpeerakool ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Medroxyprogesterone Acetate ◽  
Case Control Study ◽  
Case Control ◽  
Depot Medroxyprogesterone Acetate ◽  
Control Study

scholarly journals Initiating intramuscular depot medroxyprogesterone acetate 24–48 hours after mifepristone administration does not affect success of early medical abortion

2018 ◽  
Vol 44 (4) ◽  
pp. 242-247 ◽  
Author(s):  
Christina Lang ◽  
Zhong Eric Chen ◽  
Anne Johnstone ◽  
Sharon Cameron
Keyword(s):  
Medroxyprogesterone Acetate ◽  
Case Control Study ◽  
Hormonal Contraception ◽  
Medical Abortion ◽  
Case Control ◽  
Primary Objective ◽  
Factors Associated ◽  
Depot Medroxyprogesterone Acetate ◽  
Increased Risk ◽  
Control Study

ObjectivesThe primary objective of this study was to determine whether intramuscular depot medroxyprogesterone acetate (IM DMPA) given at the time of misoprostol administration, 24–48 hours after mifepristone, affects the rate of continuing pregnancy. In addition, the study explored factors predictive of continuing pregnancy.DesignCase-control study based on database review of women who underwent early medical abortion (EMA) over a 4-year period.SettingSingle abortion service in Scotland.Participants5122 women who underwent an EMA within the timeframe of this study.Main outcome measuresContinuing pregnancies among women receiving IM DMPA were compared with those choosing other hormonal methods of contraception, non-hormonal contraception or no contraception at the time of misoprostol administration. Logistic regression was performed to assess the effects of demographic characteristics, gestation at presentation and method of contraception provided, on outcome of pregnancy.ResultsA total of 4838 women with complete data were included, of which there were 20 continuing pregnancies (0.4%); 284 women were excluded due to missing data. There was no increased risk of a continuing pregnancy among women who initiated IM DMPA at the time of misoprostol administration (24–48 hours after mifepristone) compared with women who initiated no hormonal contraception at this time (RR 0.48; 95% CI 0.06 to 3.81). Gestation ≥8 weeks and previous terminations were factors associated with increased likelihood of continuing pregnancy.ConclusionsWomen choosing IM DMPA after EMA can be reassured that IM DMPA can be safely initiated at the time of misoprostol administration 24–48 hours after mifepristone without an increase in the risk of a continuing pregnancy. Both increasing gestation and previous termination were factors associated with an increased likelihood of continuing pregnancy following an EMA.

The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK

2016 ◽  
Vol 28 (1) ◽  
pp. 291-297 ◽  
Author(s):  
I. Kyvernitakis ◽  
K. Kostev ◽  
T. Nassour ◽  
F. Thomasius ◽  
P. Hadji
Keyword(s):  
Fracture Risk ◽  
Medroxyprogesterone Acetate ◽  
Case Control Study ◽  
Case Control ◽  
Depot Medroxyprogesterone Acetate ◽  
The Uk ◽  
The Impact ◽  
Control Study

scholarly journals Early menarche and teenager pregnancy as risk factors for morbid obesity among reproductive-age women: A case-control study

Clinics ◽  
2017 ◽  
Vol 72 (09) ◽  
pp. 547-553 ◽  
Author(s):  
AG Neves ◽  
KT Kasawara ◽  
AC Godoy-Miranda ◽  
FH Oshika ◽  
EA Chaim ◽  
...  
Keyword(s):  
Risk Factors ◽  
Morbid Obesity ◽  
Case Control Study ◽  
Case Control ◽  
Reproductive Age ◽  
Early Menarche ◽  
Reproductive Age Women ◽  
Control Study

Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study

1996 ◽  
Vol 103 (9) ◽  
pp. 909-914 ◽  
Author(s):  
Pisake Lumbiganon ◽  
Sungwal Rugpao ◽  
Surang Phandhu-fung ◽  
Malinee Laopaiboon ◽  
Nara Vudhikamraksa ◽  
...  
Keyword(s):  
Protective Effect ◽  
Medroxyprogesterone Acetate ◽  
Case Control Study ◽  
Case Control ◽  
Uterine Leiomyomas ◽  
Depot Medroxyprogesterone Acetate ◽  
Control Study
Sign in / Sign up

Export Citation Format

Share Document